83-5967-89　TAG-72, Minretumomab Biosimilar 100ug　592006

特徴

• Minretumomab is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen.
• This includes breast, colon, lung, and pancreatic cancers.
• A wide range of derivatives has been used in pharmaceutical research.
• Examples include chimeric and humanized minretumomab, as well as a fusion protein of a minretumomab single-chain variable fragment and the enzyme beta-lactamase.
• Applications:Suitable for use in ELISA, Neutralization, Functional Assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Minretumomab.
• Other applications not tested.
• Recommended Dilution:Optimal dilutions to be determined by the researcher.
• Storage and Stability:May be stored at 4℃ for short-term only.
• Aliquot to avoid repeated freezing and thawing.
• Store at -20℃.
• Aliquots are stable for 12 months after receipt.
• For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.